antibody

Documents about antibody

• Changes in Anti-HBc Positivity and Antibody Loss in Immunocompromised Patients: An Eight-Year Hospital-Based Analysis From a Tertiary Center in Turkey.#671296NCBI PubMed Central
• A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors#802264ClinicalTrials.gov
• A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee#804260ClinicalTrials.gov
• DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma#805117ClinicalTrials.gov
• Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina#829719ClinicalTrials.gov
• Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma#833897ClinicalTrials.gov
• Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma#836768ClinicalTrials.gov
• Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases#838214ClinicalTrials.gov
• A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.#842118ClinicalTrials.gov
• TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)#862588ClinicalTrials.gov
• Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia#866879ClinicalTrials.gov
• Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia#869013ClinicalTrials.gov
• Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma#872481ClinicalTrials.gov
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix#872835ClinicalTrials.gov
• A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma#877567ClinicalTrials.gov
• Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma#885567ClinicalTrials.gov
• Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis#885793ClinicalTrials.gov
• Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia#890110ClinicalTrials.gov
• Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018–May 2019#133117Unpaywall
• Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes#325168ClinicalTrials.gov
• The role of S100A8/A9 in the pathogenesis of acute exacerbations of pulmonary fibrosis#348398OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities#348440PubMed Central
• From intracellular processing to renal phenotypes: a mechanism-informed framework for interpreting kidney injury and electrolyte patterns with antibody-drug conjugates in solid tumors.#360763NCBI PubMed Central
• Real-World Characteristics and Treatment Patterns of Calcitonin Gene-Related Peptide Monoclonal Antibody Users: a Japanese Claims Database-Based Study#368928Springer Nature OA
• Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity#379776Apollo
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.#383640ClinicalTrials.gov
• A targeted metabolic intervention via exercise applied after vaccination shapes kinetics and durability of serum antibody accompanied by a distinct immunometabolic signature: pilot study.#404328NCBI PubMed Central
• A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody#405137ClinicalTrials.gov
• The SARS-CoV-2 S2′-helix compared to stem-helix confers higher genetic barrier to antibody resistance#428186PLOS
• Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results#643353HAL (France)
• Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer#811738ClinicalTrials.gov
• AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer#831342ClinicalTrials.gov
• A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine#831516ClinicalTrials.gov
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer#835541ClinicalTrials.gov
• Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers#836075ClinicalTrials.gov
• ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body#838073ClinicalTrials.gov
• Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients#841177ClinicalTrials.gov
• Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas#844338ClinicalTrials.gov
• A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects#847042ClinicalTrials.gov
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4#848063ClinicalTrials.gov
• Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab#849113ClinicalTrials.gov
• Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS#849318ClinicalTrials.gov
• Characteristics of Young-onset Diabetes in Sub-Saharan Africa (YODA) Study#850594ClinicalTrials.gov
• Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.#854355ClinicalTrials.gov
• A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)#854579ClinicalTrials.gov
• Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)#864342ClinicalTrials.gov
• A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors#873618ClinicalTrials.gov
• Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma#876944ClinicalTrials.gov
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)#877398ClinicalTrials.gov
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes#879414ClinicalTrials.gov